This article is more than 5 years old. Information may no longer be current.
Hematology/Oncology Pharmacy Association elects new president
Click Here to Manage Email Alerts
The Hematology/Oncology Pharmacy Association elected Sarah Scarpace, PharmD, MPH, BCOP, to serve as president for the 2016-2017 term.
Scarpace is associate professor at Albany College of Pharmacy and Health Sciences. She teaches courses in oncology pharmacotherapy, oncology drug interactions and pharmacogenetics, and cancer screening, prevention and early detection.
“Sarah’s career is filled with numerous accomplishments and contributions to the field of hematology/oncology pharmacy,” Scott Soefje, PharmD, MBA, BCOP, FCCP, the association’s immediate past president, said in a press release. “Sarah has dedicated her career to academia and serving as a mentor and advisor to students entering the profession.”
Susannah Koontz, PharmD, BCOP, FHOPA, will serve as president-elect for the 2016-2017 term.
Koontz, who will assume the office of president in March 2017, is principal of Koontz Oncology Consulting. She consults for pharmacy practice, medical education and clinical research in the fields of pediatric hematology, oncology and stem cell transplantation.
Edward Li, PharmD, MPH, BCOP, has been selected as an at-large member for the association’s board of directors.
Li, who most recently served as vice chair of the association’s health policy committee, is associate professor of pharmacy practice at University of New England College of Pharmacy in Maine. His research focuses on pharmacoeconomics, pharmacoepidemiology and evaluation of health policy issues as they relate to oncology practice.